Biology subjects

Adrian-Hamazaki, A.

Publications and source records attributed to Adrian-Hamazaki, A..

3 recordsLinked to original sources

bioRxiv2026

Chromosomal mutational signatures of DNA damaging agents at single cell resolution

The chromosomal-scale mutational spectrum of small molecules that interact with DNA has been hard to study at scale, as mutational events are distributed in location and occur in parallel in different cells. Here, we present a framework that pairs phylogenetic ancestry reconstruction with mutational signature decomposition to characterise recent, cell-private copy number alteration (CNA) mutational patterns at single-cell resolution. We used this framework to characterise the cell-wise mutational spectrum of contemporaneous CNAs generated by double-strand-break-inducing chemotherapeutic drugs. We demonstrate that platinum salts, G-quadruplex stabilizers and topoisomerase II inhibitors, although mechanistically distinct, converge on a mutational signature dominated by telomere-bounded copy-number gains and losses. This signature is observed in different genetic backgrounds and in vivo in drug-treated patient-derived xenografts. We also observe a high rate of endogenous telomere-bounded mutational foreground in BRCA1 deficient cells. We show that the single cell genome derived signature exposures are drug dose-dependent, and use this to identify the decay of mutational load after drug withdrawal. We observe that both cisplatin and a G4 binder molecule (CX5461) exhibit foreground mutational signature persistence for at least 3 weeks after drug withdrawal, suggesting that residual effects of exposure may last longer than anticipated. Finally, extending the framework to serially drug-treated patient-derived xenograft (PDX) models, we show that telomere-bounded CNA signature exposure is associated with tumoural response to drug, consistent with loss of mutational activity on the genome after acquired resistance emerges. Together, our results show that our framework applied on scWGS identifies contemporaneous chromosomal mutation patterns induced by small molecules in human tissues.

cancer biology↗

bioRxiv2026

Gene function prediction from bulk coexpression is bounded by cell-type-level signal

It is widely accepted in genomics that coexpression of RNA transcripts suggests a commonality of function. This intuition is explicitly leveraged in machine learning methods that predict gene function, where it is often combined with other features such as protein interactions and sequence similarity. For example, including coexpression data from human tissue expression boosts performance for predicting Gene Ontology annotations. However, the biological underpinnings of this observation have not been well-investigated. Building on earlier results from our group, in this work we show that gene function is predictable from coexpression substantially because it reflects differences in expression between cell types, and these differences are also intrinsic to the ground truth labels. Using simulations and analyses of real data, we show that variance in the cellular composition of bulk samples impacts function learnability and attribute this to cell type marker gene content in the GO terms. We further show that cell type profiles, where the relationship between gene expression and cell type is made transparent, are effective for predicting gene function while increasing interpretability. These results indicate that function prediction models trained on bulk coexpression are largely limited to cell-type-level resolution rather than fine-grained biochemical function, with direct consequences for how such predictions should be interpreted.

bioinformatics↗

bioRxiv2022

Characterizing the targets of transcription regulators by aggregating ChIP-seq and perturbation expression data sets

Mapping the gene targets of chromatin-associated transcription regulators (TRs) is a major goal of genomics research. ChIP-seq of TRs and experiments that perturb a TR and measure the differential abundance of gene transcripts are a primary means by which direct relationships are tested on a genomic scale. It has been reported that there is poor overlap in the evidence across gene regulation strategies, emphasizing the need for integrating results from multiple experiments. While research consortia interested in gene regulation have produced a valuable trove of high-quality data, there is an even greater volume of TR-specific data throughout the literature. In this study, we demonstrate a workflow for the identification, uniform processing, and aggregation of ChIP-seq and TR perturbation experiments for the ultimate purpose of ranking human and mouse TR-target interactions. Focusing on an initial set of eight regulators (ASCL1, HES1, MECP2, MEF2C, NEUROD1, PAX6, RUNX1, and TCF4), we identified 497 experiments suitable for analysis. We used this corpus to examine data concordance, to identify systematic patterns of the two data types, and to identify putative orthologous interactions between human and mouse. We build upon commonly used strategies to forward a procedure for aggregating and combining these two genomic methodologies, assessing these rankings against independent literature-curated evidence. Beyond a framework extensible to other TRs, our work also provides empirically ranked TR-target listings, as well as transparent experiment-level gene summaries for community use.

bioinformatics↗